Abbey E Poirier1, Anne Grundy1, Farah Khandwala1, Sierra Tamminen1, Christine M Friedenreich1, Darren R Brenner1. 1. Department of Cancer Epidemiology and Prevention Research (Poirier, Grundy, Khandwala, Tamminen, Friedenreich, Brenner) CancerControl Alberta, Alberta Health Services; Alberta Cancer Prevention Legacy Fund, Population, Public and Aboriginal Health, Alberta Health Services; Department of Oncology (Friedenreich, Brenner), Cumming School of Medicine, University of Calgary; Department of Community Health Sciences (Friedenreich, Brenner), Cumming School of Medicine, University of Calgary, Calgary, Alta.
Abstract
BACKGROUND: Strong and consistent epidemiologic evidence shows that tobacco smoking causes cancers at various sites. The purpose of this study was to quantify the proportion and total number of site-specific cancers in Alberta attributable to tobacco exposure. METHODS: The proportion of incident cancer cases attributable to active and passive tobacco exposure in Alberta was estimated with population attributable risks. Data from the Canadian Community Health Survey (CCHS) for 2000-2007 were used to estimate prevalence of active (current or former smoker) and passive (second-hand smoke) tobacco exposure in Alberta. RESULTS: According to the 2000/01 CCHS, 29.1% and 38.6% of Albertans were estimated to be current and former smokers, respectively. According to the 2003 CCHS, 23.7% of Albertans who had never smoked reported regular second-hand exposure to tobacco. Population attributable risk estimates for tobacco-related cancer sites ranged from about 4% for ovarian cancer to 74% for laryngeal cancer. About 5% of incident lung cancers in men and women who never smoked could be attributed to passive tobacco exposure. Overall, 37.0% of tobacco-related cancers in Alberta (or 15.7% of all cancers) were estimated to be attributable to active tobacco smoking in 2012. INTERPRETATION: A notable proportion of cancers associated with tobacco use were estimated to be attributable to active smoking in Alberta. Strategies to reduce the prevalence of active tobacco smoking in Alberta could have a considerable impact on future cancer incidence.
BACKGROUND: Strong and consistent epidemiologic evidence shows that tobacco smoking causes cancers at various sites. The purpose of this study was to quantify the proportion and total number of site-specific cancers in Alberta attributable to tobacco exposure. METHODS: The proportion of incident cancer cases attributable to active and passive tobacco exposure in Alberta was estimated with population attributable risks. Data from the Canadian Community Health Survey (CCHS) for 2000-2007 were used to estimate prevalence of active (current or former smoker) and passive (second-hand smoke) tobacco exposure in Alberta. RESULTS: According to the 2000/01 CCHS, 29.1% and 38.6% of Albertans were estimated to be current and former smokers, respectively. According to the 2003 CCHS, 23.7% of Albertans who had never smoked reported regular second-hand exposure to tobacco. Population attributable risk estimates for tobacco-related cancer sites ranged from about 4% for ovarian cancer to 74% for laryngeal cancer. About 5% of incident lung cancers in men and women who never smoked could be attributed to passive tobacco exposure. Overall, 37.0% of tobacco-related cancers in Alberta (or 15.7% of all cancers) were estimated to be attributable to active tobacco smoking in 2012. INTERPRETATION: A notable proportion of cancers associated with tobacco use were estimated to be attributable to active smoking in Alberta. Strategies to reduce the prevalence of active tobacco smoking in Alberta could have a considerable impact on future cancer incidence.
Authors: Gina D Tran; Xiu-Di Sun; Christian C Abnet; Jin-Hu Fan; Sanford M Dawsey; Zhi-Wei Dong; Steven D Mark; You-Lin Qiao; Philip R Taylor Journal: Int J Cancer Date: 2005-01-20 Impact factor: 7.396
Authors: H Tulinius; N Sigfússon; H Sigvaldason; K Bjarnadóttir; L Tryggvadóttir Journal: Cancer Epidemiol Biomarkers Prev Date: 1997-11 Impact factor: 4.254
Authors: Kelvin K F Tsoi; Carol Y Y Pau; William K K Wu; Francis K L Chan; Sian Griffiths; Joseph J Y Sung Journal: Clin Gastroenterol Hepatol Date: 2009-02-24 Impact factor: 11.382
Authors: Darren R Brenner; Abbey E Poirier; Stephen D Walter; Will D King; Eduardo L Franco; Paul A Demers; Paul J Villeneuve; Yibing Ruan; Farah Khandwala; Xin Grevers; Robert Nuttall; Leah Smith; Prithwish De; Karena Volesky; Dylan O'Sullivan; Perry Hystad; Christine M Friedenreich Journal: BMJ Open Date: 2018-08-01 Impact factor: 2.692
Authors: Elizabeth Blackman; Kimlin Ashing; Denise Gibbs; Yin-Ming Kuo; Andrew Andrews; Meganathan Ramakodi; Karthik Devarajan; Jackie Bucci; Gilda Jean-Louis; Oni Richards-Waritay; Barbara Wilson; Carlene Bowen; Eric Edi; Vera Tolbert; Raphiatou Noumbissi; Daramola N Cabral; JoAnn Oliver; Robin Roberts; Marshall Tulloch-Reid; Camille Ragin Journal: Ethn Health Date: 2018-11-19 Impact factor: 2.732